IMR logo

Imricor Medical Systems, Inc. Stock Price

ASX:IMR Community·AU$439.7m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 6 Fair Values set on narratives written by author

IMR Share Price Performance

AU$1.37
0.44 (47.31%)
AU$1.37
0.44 (47.31%)
Price AU$1.37

IMR Community Narratives

There are no narratives available yet.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Adequate balance sheet with low risk.

3 Risks
1 Reward

Imricor Medical Systems, Inc. Key Details

US$748.5k

Revenue

US$1.7m

Cost of Revenue

-US$998.8k

Gross Profit

US$35.0m

Other Expenses

-US$36.0m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-0.11
-133.44%
-4,806.13%
103.0%
View Full Analysis

About IMR

Founded
2006
Employees
n/a
CEO
Steven Wedan
WebsiteView website
www.imricor.com

Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East. The company’s product includes the Advantage-MR EP Recorder/Stimulator system, an EP recording system and cardiac stimulator. Its products also include Vision-MR Ablation Catheter, which is used as an indication for treating type I atrial flutter; and Vision-MR Dispersive Electrode that is used to minimize eddy currents induced on the conductive pads during MR scanning. Imricor Medical Systems, Inc. was incorporated in 2006 and is headquartered in Burnsville, Minnesota.

Recent IMR News & Updates

Recent updates

No updates